Regulatory Open Forum

Your input is needed on a survey to learn about current progress toward FDA's draft guidance on Diversity Plans. Please take 2 minutes to complete the survey by September 28, 2023.

Last year, FDA released a draft guidance recommending that sponsors submit Diversity Plans to improve representation in clinical trials. In Diversity Plans, sponsors set goals and develop strategies to increase participation of underrepresented racial and ethnic groups.

We can all benefit from learning more about progress toward enhancing diversity in drug development, so please share your thoughts. We will share all results!

Please access the survey HERE or at the QR code below:

Great idea to do this survey. Will you be posting the results?

Your input is needed on a survey to learn about current progress toward FDA's draft guidance on Diversity Plans. Please take 2 minutes to complete the survey by September 28, 2023.

Last year, FDA released a draft guidance recommending that sponsors submit Diversity Plans to improve representation in clinical trials. In Diversity Plans, sponsors set goals and develop strategies to increase participation of underrepresented racial and ethnic groups.

We can all benefit from learning more about progress toward enhancing diversity in drug development, so please share your thoughts. We will share all results!

Please access the survey HERE or at the QR code below: